DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Yoon JH, Yhim HY, Kwak JY. et al.
Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ann Oncol 2016;
27 (06) 1081-1088
We do not assume any responsibility for the contents of the web pages of other providers.